| Ytd | 5.70% | |
| 1y | 30.35% |
| Open | 23.97 | Prev Close | 24.11 | Low | 23.41 | High | 24.02 | Mkt Cap | 11.95B |
| Vol | 5.36M | Avg Vol | 6.04M | EPS | -0.41 | P/E | N/A | Forward P/E | 18.69 |
| Beta | 1.67 | Short Ratio | 3.81 | Inst. Own | 115.49% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 24.59 | 200-d Avg | 23.68 | 1yr Est | 31.21 |
Corient Private Wealth LP purchased a new stake in shares of Elanco Animal Health Incorporated (NYSE
Corient Private Wealth LP raised its stake in Elanco Animal Health Incorporated (NYSE: ELAN) by 127.
Algert Global LLC trimmed its holdings in Elanco Animal Health Incorporated (NYSE: ELAN) by 19.0% du
The completed 25,000-square-foot Elwood site expansion bolsters Elanco's monoclonal antibody (mA
The completed 25,000-square-foot Elwood site expansion bolsters Elanco's monoclonal antibody (mAb) p
Bryn Talkington picked Horizon Kinetics, Stephanie Link chose Elanco Animal Health, and Jason Snipe
UBS analyst Andrea Alfonso maintains Elanco Animal Health (NYSE:ELAN) with a Buy and raises the p
Keybanc analyst Steve Dechert maintains Elanco Animal Health (NYSE:ELAN) with a Overweight and r
Elanco beat second-quarter estimates, raised 2026 guidance and cited strong Pet Health demand, Zenre
US stocks rise, Wynn Resorts beat earnings expectations, share price jumps 10.9%. Other companies re
Elanco Animal Health (NYSE:ELAN) is looking for Q3 Adj EPS of $0.19-$0.22 vs $0.20 analyst estimate.
Elanco Animal Health (NYSE:ELAN) raises FY2026 Adj EPS guidance from $1.03-$1.09 to $1.10-$1.16 vs $